Solutions clinical trials
How each study uses Solutions is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Solutions studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
4 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2020 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 2
Baxalta now part of Shire (1) · Boehringer Ingelheim (1) · Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation (1) · Lithuanian University of Health Sciences (1)
Often tested with
Tested in the same studies.
Immunoglobulins, Intravenous (1) · Immunoglobulin G (1) · Immunoglobulins (1) · 5,11-dihydro-11-ethyl-5-methyl-8-(2-(1-oxido-4-quinolinyl)ethyl)-6H-dipyrido(3,2-B,2',3'-E)(1,4)diazepin-6-one (1) · Bilr 355 (1) · Ritonavir (1) · Local anesthetics (1)
Studies
Open first, then newest update. How each study uses Solutions is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Clinical Study of the Safety and Pharmacokinetics of the Drug Fluorothiazinone, a Concentrate for Solution Preparation for Infusion.Not yet recruitingPhase 1Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian FederationNCT07184606Written as ¼ of the full (target) dose (solution, 5 ml)
- A Study of Immune Globulin Subcutaneous (Human), 20% Solution (IGSC, 20%) in Japanese Participants With Primary Immunodeficiency Diseases (PID)CompletedPhase 3Baxalta now part of ShireNCT04346108Written as Immune Globulin Subcutaneous, 20% Solution (IGSC, 20%)
- The Efficacy of Local Infiltration Analgesia for Postoperative Pain Management After Total Knee ArthroplastyStatus unknownNot applicableLithuanian University of Health SciencesNCT04258241Written as Solution with local anesthetic
- Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of BILR 355 BS Plus Low Dose Ritonavir in HIV-uninfected Male VolunteersCompletedPhase 1Boehringer IngelheimNCT02253914Written as BILR 355 BS, solution